ATRA
Atara Biotherapeutics Inc
9.50$
+12.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +98.9% | +543.4% | +4.7% | +40.3% | -18.5% | +199.7% | -82.1% | -80.4% | -53.8% | -67.6% | +22.1% | – | |
| – | +20.8% | -37.2% | +133.1% | +64.3% | -10.6% | +200.8% | -97.3% | -79.2% | -9.6% | +19.2% | +54.0% | – | |
| – | – | +2,223.4% | -5.4% | +35.7% | -20.3% | +199.4% | -78.1% | -80.4% | -55.3% | -73.7% | +12.0% | – | |
| – | -22.7% | +3.5% | -26.8% | +31.8% | -34.6% | -4.5% | -73.4% | -60.0% | -92.4% | -26.5% | +720.1% | – | |
| – | -6.5% | -3.0% | -19.8% | +16.9% | -9.4% | +21.6% | -48.3% | -32.8% | +7.3% | -15.9% | +6.0% | – | |
| – | -21.4% | +4.1% | -25.4% | +28.6% | -29.8% | +2.0% | -64.5% | -50.0% | -41.3% | -7.2% | +37.2% | – | |
| – | – | – | – | – | – | – | -91.8% | -211.8% | – | – | – | – | |
| – | -15.7% | -2.0% | +9.5% | -6.3% | -14.0% | +0.0% | -4.4% | -6.5% | -1.7% | -7.2% | -77.0% | – | |
| – | – | – | – | – | – | – | -93.7% | -278.9% | – | – | – | – | |
| – | – | +118.2% | +714,237.5% | -100.0% | – | – | – | +833.3% | – | – | – | – | |
| – | – | – | – | – | – | – | -93.7% | -280.3% | – | – | – | – | |
| – | – | – | – | – | – | – | -91.2% | -192.6% | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.